ALISA NATER TORRES: Open Payments
NPI 1245935493 · PORTSMOUTH, VA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$293 in 10 payments from 7 companies in 2025. Trend: 2023 $262 · 2024 $1,288 · 2025 $293
Food & beverage: $293
| Company | Payments | Amount |
|---|---|---|
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 3 | $146 |
| Teva Pharmaceuticals USA, Inc. | 2 | $37 |
| Axsome Therapeutics, Inc. | 1 | $29 |
| Corium, LLC | 1 | $26 |
| Alkermes, Inc. | 1 | $24 |
| E.R. Squibb & Sons, L.L.C. | 1 | $16 |
| Neurocrine BioSciences, Inc. | 1 | $15 |
Products named: CAPLYTA, UZEDY, Auvelity, Azstarys, ARISTADA, COBENFY, INGREZZA.
Industry payments across VA — which companies pay providers there.
